...
机译:循环肿瘤DNA对晚期非小细胞肺癌基因突变动态监测的测序
Shenzhen Peoples Hosp Dept Oncol 1017 Dongmen North Rd Shenzhen 518000 Guangdong Peoples R;
HaploX Biotechnol Co Ltd 3 Songpingshan Rd Shenzhen 518000 Guangdong Peoples R China;
HaploX Biotechnol Co Ltd 3 Songpingshan Rd Shenzhen 518000 Guangdong Peoples R China;
Shenzhen Peoples Hosp Dept Oncol 1017 Dongmen North Rd Shenzhen 518000 Guangdong Peoples R;
Shenzhen Peoples Hosp Dept Oncol 1017 Dongmen North Rd Shenzhen 518000 Guangdong Peoples R;
HaploX Biotechnol Co Ltd 3 Songpingshan Rd Shenzhen 518000 Guangdong Peoples R China;
HaploX Biotechnol Co Ltd 3 Songpingshan Rd Shenzhen 518000 Guangdong Peoples R China;
HaploX Biotechnol Co Ltd 3 Songpingshan Rd Shenzhen 518000 Guangdong Peoples R China;
HaploX Biotechnol Co Ltd 3 Songpingshan Rd Shenzhen 518000 Guangdong Peoples R China;
HaploX Biotechnol Co Ltd 3 Songpingshan Rd Shenzhen 518000 Guangdong Peoples R China;
circulating tumor DNA; lung cancer; epithelial growth factor receptor T790M mutation; drug resistance;
机译:循环肿瘤DNA对晚期非小细胞肺癌基因突变动态监测的测序
机译:P2.01-130通过循环肿瘤DNA的下一代测序检测高级非小细胞肺癌中可操作突变状态
机译:通过下一代测序评价的循环肿瘤DNA是通过在先进的非小细胞肺癌中预测肿瘤反应和Nivolumab的延长临床益处
机译:接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
机译:NAD(P)H:醌氧化还原酶1在非小细胞肺癌的发生和肺癌干细胞维持中的作用
机译:循环肿瘤DNA测序可动态监测晚期非小细胞肺癌的基因突变
机译:循环肿瘤DNA对晚期非小细胞肺癌基因突变动态监测的测序